Free Trial

This company has been marked as potentially delisted and may not be actively trading.

TFF Pharmaceuticals (TFFP) Competitors

TFF Pharmaceuticals logo

TFFP vs. AIMDW, ALVOW, ACABW, RNA, and BFRIW

Should you be buying TFF Pharmaceuticals stock or one of its competitors? The main competitors of TFF Pharmaceuticals include Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Avidity Biosciences (RNA), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does TFF Pharmaceuticals compare to Ainos?

TFF Pharmaceuticals (NASDAQ:TFFP) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.

Company Net Margins Return on Equity Return on Assets
TFF PharmaceuticalsN/A N/A N/A
Ainos N/A N/A N/A

Ainos has lower revenue, but higher earnings than TFF Pharmaceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TFF Pharmaceuticals$730K0.40-$21.24M-$6.44N/A
Ainos$124.16KN/AN/AN/AN/A

In the previous week, TFF Pharmaceuticals' average media sentiment score of 0.00 equaled Ainos'average media sentiment score.

Company Overall Sentiment
TFF Pharmaceuticals Neutral
Ainos Neutral

15.3% of TFF Pharmaceuticals shares are owned by institutional investors. 4.5% of TFF Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

TFF Pharmaceuticals beats Ainos on 3 of the 3 factors compared between the two stocks.

How does TFF Pharmaceuticals compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and TFF Pharmaceuticals (NASDAQ:TFFP) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, dividends, analyst recommendations, valuation and media sentiment.

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
TFF Pharmaceuticals N/A N/A N/A

Alvotech has higher revenue and earnings than TFF Pharmaceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$586.32MN/AN/AN/AN/A
TFF Pharmaceuticals$730K0.40-$21.24M-$6.44N/A

In the previous week, Alvotech's average media sentiment score of 0.00 equaled TFF Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Alvotech Neutral
TFF Pharmaceuticals Neutral

15.3% of TFF Pharmaceuticals shares are owned by institutional investors. 4.5% of TFF Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

TFF Pharmaceuticals beats Alvotech on 2 of the 3 factors compared between the two stocks.

How does TFF Pharmaceuticals compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and TFF Pharmaceuticals (NASDAQ:TFFP) are both pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, dividends, analyst recommendations, valuation and media sentiment.

Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. IIN/A N/A N/A
TFF Pharmaceuticals N/A N/A N/A

Atlantic Coastal Acquisition Corp. II has higher earnings, but lower revenue than TFF Pharmaceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A
TFF Pharmaceuticals$730K0.40-$21.24M-$6.44N/A

In the previous week, Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled TFF Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
TFF Pharmaceuticals Neutral

15.3% of TFF Pharmaceuticals shares are owned by institutional investors. 4.5% of TFF Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

TFF Pharmaceuticals beats Atlantic Coastal Acquisition Corp. II on 3 of the 3 factors compared between the two stocks.

How does TFF Pharmaceuticals compare to Avidity Biosciences?

Avidity Biosciences (NASDAQ:RNA) and TFF Pharmaceuticals (NASDAQ:TFFP) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, dividends, analyst recommendations, valuation and media sentiment.

15.3% of TFF Pharmaceuticals shares are held by institutional investors. 3.8% of Avidity Biosciences shares are held by company insiders. Comparatively, 4.5% of TFF Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

TFF Pharmaceuticals has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. TFF Pharmaceuticals' return on equity of 0.00% beat Avidity Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Avidity Biosciences-3,650.39% -44.92% -39.57%
TFF Pharmaceuticals N/A N/A N/A

Avidity Biosciences presently has a consensus target price of $69.42, indicating a potential upside of 437.73%. Given Avidity Biosciences' stronger consensus rating and higher possible upside, equities research analysts clearly believe Avidity Biosciences is more favorable than TFF Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avidity Biosciences
1 Sell rating(s)
12 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.32
TFF Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

TFF Pharmaceuticals has lower revenue, but higher earnings than Avidity Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avidity Biosciences$18.62MN/A-$322.30MN/AN/A
TFF Pharmaceuticals$730K0.40-$21.24M-$6.44N/A

In the previous week, Avidity Biosciences had 1 more articles in the media than TFF Pharmaceuticals. MarketBeat recorded 1 mentions for Avidity Biosciences and 0 mentions for TFF Pharmaceuticals. Avidity Biosciences' average media sentiment score of 0.00 equaled TFF Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Avidity Biosciences Neutral
TFF Pharmaceuticals Neutral

Summary

TFF Pharmaceuticals beats Avidity Biosciences on 7 of the 13 factors compared between the two stocks.

How does TFF Pharmaceuticals compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and TFF Pharmaceuticals (NASDAQ:TFFP) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, profitability and media sentiment.

15.3% of TFF Pharmaceuticals shares are held by institutional investors. 4.5% of TFF Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
TFF Pharmaceuticals N/A N/A N/A

Biofrontera has higher revenue and earnings than TFF Pharmaceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$41.71MN/AN/AN/AN/A
TFF Pharmaceuticals$730K0.40-$21.24M-$6.44N/A

In the previous week, Biofrontera had 1 more articles in the media than TFF Pharmaceuticals. MarketBeat recorded 1 mentions for Biofrontera and 0 mentions for TFF Pharmaceuticals. Biofrontera's average media sentiment score of 0.00 equaled TFF Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Biofrontera Neutral
TFF Pharmaceuticals Neutral

Summary

Biofrontera and TFF Pharmaceuticals tied by winning 2 of the 4 factors compared between the two stocks.

Get TFF Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TFFP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TFFP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TFFP vs. The Competition

MetricTFF PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market CapN/A$3.40B$6.25B$11.76B
Dividend YieldN/A2.23%2.74%5.26%
P/E Ratio-0.0138.5729.2427.07
Price / Sales0.40280.01504.6873.40
Price / CashN/A125.0643.3053.90
Price / BookN/A7.059.676.69
Net Income-$21.24M$23.62M$3.55B$332.64M

TFF Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TFFP
TFF Pharmaceuticals
N/A$0.07
flat
N/AN/A$0.00$730KN/A19
AIMDW
Ainos
N/A$0.09
+3.1%
N/A-65.4%$0.00$124.16KN/A40
ALVOW
Alvotech
N/A$0.21
-18.2%
N/AN/A$0.00$586.32MN/A4
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat
N/AN/A$0.00N/AN/A15
RNA
Avidity Biosciences
1.322 of 5 stars
$12.99
+3.5%
$69.42
+434.4%
-60.0%$0.00$18.62MN/A190

Related Companies and Tools


This page (NASDAQ:TFFP) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners